scholarly journals Gene expression in term placentas is regulated more by spinal or epidural anesthesia than by late-onset preeclampsia or gestational diabetes mellitus

2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Tove Lekva ◽  
Robert Lyle ◽  
Marie Cecilie Paasche Roland ◽  
Camilla Friis ◽  
Diana W. Bianchi ◽  
...  
2013 ◽  
Vol 29 (4) ◽  
pp. 331-335 ◽  
Author(s):  
Kalliopi I. Pappa ◽  
Maria Gazouli ◽  
Eleni Anastasiou ◽  
Zoe Iliodromiti ◽  
Aristides Antsaklis ◽  
...  

2011 ◽  
Vol 50 (2) ◽  
pp. 201-208 ◽  
Author(s):  
Cristina López-Tinoco ◽  
Mar Roca ◽  
Amor García-Valero ◽  
Mora Murri ◽  
Francisco J. Tinahones ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Anna Maria Nuzzo ◽  
Domenica Giuffrida ◽  
Laura Moretti ◽  
Paola Re ◽  
Giorgio Grassi ◽  
...  

AbstractGestational diabetes mellitus (GDM) and preeclampsia (PE) are both characterized by endothelial dysfunction and GDM women have higher incidence of PE. The placenta plays a key role in PE pathogenesis but its contribution to PE during GDM remains unclear. Herein, we compared placental and maternal blood anti-angiogenic soluble fms-like tyrosine kinase-1 (sFlt1) and pro-angiogenic Placental Growth Factor (PlGF) expressions in GDM and GDM-PE pregnancies compared to controls (CTRL) and PE cases. Electrochemiluminescence immunoassays showed a significantly higher maternal blood sFlt1/PlGF values in GDM-PE relative to CTRL and GDM pregnancies. We reported that placental PlGF gene expression was significantly decreased in GDM, PE and GDM-PE relative to CTRL. However, PlGF protein levels were significantly increased in GDM and GDM-PE relative to CTRL and PE placentae. Finally, sFlt1 gene expression was significantly increased in PE relative to CTRL, GDM and GDM-PE placentae. In contrast, sFlt1 protein expression was significantly decreased in GDM-PE relative to CTRL, GDM and PE placentae. Finally, higher sFlt1/PlGF ratio in GDM-PE maternal blood suggest that sFlt1 overproduction is related to PE onset also in GDM pregnancies even though characterized by a less severe endothelial dysfunction in terms of angiogenic biomarkers.


2021 ◽  
Vol 12 ◽  
Author(s):  
Ning Wang ◽  
Bo Sun ◽  
Haonan Guo ◽  
Yingyu Jing ◽  
Qi Ruan ◽  
...  

ObjectiveTo study the discrepancy of the insulin sensitivity alteration pattern, circulating fibroblast growth factor (FGF21) levels and FGF21 signaling in visceral white adipose tissue (vWAT) of gestational diabetes mellitus (GDM) subtypes.Methods26 GDM women with either a predominant of insulin-secretion defect (GDM-dysfunction, n = 9) or insulin-sensitivity defect (GDM-resistance, n = 17) and 13 normal glucose tolerance (NGT) women scheduled for caesarean-section at term were studied. Blood and vWAT samples were collected at delivery.ResultsThe insulin sensitivity was improved from the 2nd trimester to delivery in the GDM-resistance group. Elevated circulating FGF21 concentration at delivery, increased FGF receptor 1c and decreased klotho beta gene expression, enhanced ERK1/2 phosphorylation, and increased GLUT1, IR-B, PPAR-γ gene expression in vWAT were found in the GDM-resistance group as compared with the NGT group. The circulating FGF21 concentration was negatively correlated with fasting blood glucose (r = -0.574, P < 0.001), and associated with the GDM-resistance group (r = 0.574, P < 0.001) in pregnant women at delivery. However, we observed no insulin sensitivity alteration in GDM-dysfunction and NGT groups during pregnancy. No differences of plasma FGF21 level and FGF21 signaling in vWAT at delivery were found between women in the GDM-dysfunction and the NGT group.ConclusionsWomen with GDM heterogeneity exhibited different insulin sensitivity alteration patterns. The improvement of insulin sensitivity may relate to the elevated circulating FGF21 concentration and activated FGF21 signaling in vWAT at delivery in the GDM-resistance group.


Sign in / Sign up

Export Citation Format

Share Document